ClinConnect ClinConnect Logo
Search / Trial NCT06705413

Effect of Lifestyle Modification on Obese Females With Primary Dysmenorrhea

Launched by CAIRO UNIVERSITY · Nov 22, 2024

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how lifestyle changes can affect the pain caused by primary dysmenorrhea, which is a type of menstrual pain, in young women who are overweight. The researchers want to see if making healthier choices, like improving diet and increasing activity, can help reduce this pain. The study is not yet open for participants, but it will focus on females aged 18 to 25 who have moderate to severe menstrual pain and a body mass index (BMI) over 30, indicating obesity.

To join the study, participants must be healthy young women who have regular menstrual cycles and haven’t engaged in sports or dieting for at least a year. However, those with certain health conditions, like pelvic diseases or a history of significant medical issues, won't be eligible. If chosen to participate, women can expect to learn more about lifestyle changes and how these might help with their pain during menstruation. It’s a chance to be part of research that could lead to better management of menstrual pain for others in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Young females with moderate to severe primary dysmenorrhea (Visual analogue scale \> 4).
  • Virgin, nonsmokers.
  • Young female aged from 18-25 years with BMI more than 30 kg/m².
  • They have regular menstrual cycles (a menstrual flow of 38 days, with 21-35 days between menstrual flows)
  • They have not practiced sports for at least one year before entering the study.
  • They have not engaged in diet for at least one year before entering the study.
  • Exclusion Criteria:
  • Any participant having Secondary dysmenorrhea (associated with identifiable pelvic pathology).
  • Any participant with a history of pelvic inflammatory disease, myoma and tumors, pelvic infection, ovarian cyst, any gynecological disease.
  • Any participant with a history of previous spinal surgeries.
  • Any participant with a history of Anemia, diabetes, hypertension, cardiovascular disease, thyroid disease, neurological disorder, rheumatoid arthritis, bariatric surgery, or taking weight loss medication.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Ismailia, , Egypt

Patients applied

0 patients applied

Trial Officials

Doaa Osman, professor

Study Director

Cairo University

Amel Yousef, Professor

Study Chair

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported